Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PIK3C3 | Q8NEB9 | 1/20 | 0.41 |
| ▸ | CA2 | P00918 | 2/20 | 0.40 |
| ▸ | MAOA | P21397 | 2/20 | 0.39 |
| ▸ | MAOB | P27338 | 2/20 | 0.39 |
| ▸ | MMP9 | P14780 | 1/20 | 0.38 |
| ▸ | NPC1 | O15118 | 1/20 | 0.36 |
| ▸ | RAB9A | P51151 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.36 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
| ▸ | MEN1 | O00255 | 3/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.35 |
| ▸ | USP2 | O75604 | 2/20 | 0.34 |
| ▸ | CA12 | O43570 | 2/20 | 0.34 |
| ▸ | RECQL | P46063 | 1/20 | 0.34 |
| ▸ | CA1 | P00915 | 1/20 | 0.34 |
| ▸ | CA7 | P43166 | 1/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17481246 | 0.81 | TYMS (0.46) | PIK3C3CA2MAOAMAOBNPC1 | |
| SCHEMBL4474802 | 0.80 | CA12 (0.51) | NPC1RAB9AALDH1A1TDP1MAPT | |
| SCHEMBL12337780 | 0.80 | ALOX15 (0.43) | CA2MAOAMAOBALDH1A1ALOX15 | |
| SCHEMBL20345840 | 0.79 | CA2 (0.33) | PIK3C3CA2NPC1RAB9AALDH1A1 | |
| SCHEMBL20548714 | 0.78 | CA2 (0.37) | PIK3C3CA2NPC1RAB9AALDH1A1 | |
| SCHEMBL20345784 | 0.77 | CA2 (0.33) | PIK3C3CA2NPC1RAB9AALDH1A1 | |
| SCHEMBL3320871 | 0.77 | ALOX15 (0.40) | CA2MAOAMAOBALDH1A1ALOX15 | |
| SCHEMBL19996956 | 0.76 | ELANE (0.49) | CA2NPC1ALDH1A1MAPTSMN1; SMN2 | |
| SCHEMBL20577752 | 0.76 | CA2 (0.51) | CA2MAOBALDH1A1TDP1MAPT | |
| SCHEMBL20346205 | 0.76 | CA2 (0.33) | PIK3C3CA2NPC1RAB9AALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 58 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11111320-B2 | Addition-fragmentation oligomers | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2021-09-07 | — | — | US | disclosed |
| EP-3326711-B1 | GRAFT COPOLYMER FUNCTIONALIZED ARTICLE | 3M INNOVATIVE PROPERTIES CO (US) | 2021-07-07 | — | — | EP | disclosed |
| EP-2675783-B1 | ADDITION-FRAGMENTATION AGENTS | 3M INNOVATIVE PROPERTIES CO (US) | 2020-04-22 | — | — | EP | disclosed |
| EP-3259323-B1 | ADDITION-FRAGMENTATION OLIGOMERS | 3M INNOVATIVE PROPERTIES CO (US) | 2020-02-26 | — | — | EP | disclosed |
| US-20200031961-A1 | ADDITION-FRAGMENTATION OLIGOMERS | 3M INNOVATIVE PROPERTIES CO (US) | 2020-01-30 | — | — | US | disclosed |
| US-10479848-B2 | Addition-fragmentation oligomers | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2019-11-19 | — | — | US | disclosed |
| US-10471398-B2 | Graft copolymer functionalized article | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2019-11-12 | — | — | US | disclosed |
| US-10370322-B2 | Addition-fragmentation agents | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2019-08-06 | — | — | US | disclosed |
| EP-3502092-A1 | ADDITION-FRAGMENTATION AGENTS | 3M Innovative Properties Company (US) | 2019-06-26 | — | — | EP | disclosed |
| US-10144760-B2 | Ligand functional substrates | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2018-12-04 | — | — | US | disclosed |
| WO-2014099317-A1 | ADDITION-FRAGMENTATION OLIGOMERS | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2014-06-26 | — | — | WO | disclosed |
| EP-2691772-A1 | LIGAND FUNCTIONAL SUBSTRATES | 3M Innovative Properties Company (US) | 2014-02-05 | — | — | EP | disclosed |
| EP-2675783-A1 | ADDITION-FRAGMENTATION AGENTS | 3M Innovative Properties Company (US) | 2013-12-25 | — | — | EP | disclosed |
| WO-2013184366-A1 | GRAFT COPOLYMER FUNCTIONALIZED ARTICLE | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2013-12-12 | — | — | WO | disclosed |
| WO-2013151739-A1 | CROSSLINKABLE COMPOSITION COMPRISING PHOTOBASE GENERATORS | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2013-10-10 | — | — | WO | disclosed |
| WO-2013028401-A1 | ADDITION-FRAGMENTATION AGENTS | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2013-02-28 | — | — | WO | disclosed |
| US-20120252091-A1 | LIGAND FUNCTIONAL SUBSTRATES | 3M INNOVATIVE PROPERTIES COMPANY | 2012-10-04 | — | — | US | disclosed |
| WO-2012134636-A1 | LIGAND FUNCTIONAL SUBSTRATES | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2012-10-04 | — | — | WO | disclosed |
| WO-2012112304-A1 | ADDITION-FRAGMENTATION AGENTS | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2012-08-23 | — | — | WO | disclosed |
| US-20120208965-A1 | ADDITION-FRAGMENTATION AGENTS | 3M INNOVATIVE PROPERTIES COMPANY | 2012-08-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10479848-B2 | Addition-fragmentation oligomers | ECPAS, ITGA8, NBAS | PIK3C3 2415/4885CA2 3834/4885MAOA 1630/4885 |
| US-10144760-B2 | Ligand functional substrates | PCNA, POLM, POLL | PIK3C3 859/4885CA2 4376/4885MAOA 3550/4885 |
| US-10370322-B2 | Addition-fragmentation agents | NR4A1, PARP14, MTX1 | PIK3C3 4732/4885CA2 3487/4885MAOA 1964/4885 |
| US-20200031961-A1 | ADDITION-FRAGMENTATION OLIGOMERS | ECPAS, ITGA8, NBAS | PIK3C3 2415/4885CA2 3834/4885MAOA 1630/4885 |
| US-11111320-B2 | Addition-fragmentation oligomers | ECPAS, ITGA8, NBAS | PIK3C3 2415/4885CA2 3834/4885MAOA 1630/4885 |
| US-20120252091-A1 | LIGAND FUNCTIONAL SUBSTRATES | PCNA, POLM, POLL | PIK3C3 859/4885CA2 4376/4885MAOA 3550/4885 |
| US-20120208965-A1 | ADDITION-FRAGMENTATION AGENTS | NR4A1, PARP14, MTX1 | PIK3C3 4732/4885CA2 3487/4885MAOA 1964/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.